Facebook
X
LinkedIn
ForwardBreaking Issues in Opioid Use Disorder Treatment
The goal of this continuing education program is to educate attendees on emerging therapeutic approaches for opioid use disorder (OUD) and barriers and facilitators regarding access to OUD treatment..
Target Audience
This course is targeted to educate Nurses, Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, and Social Workers.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Compare the mechanism, efficacy, and safety of FDA-approved medications for OUD
- Describe evidence-based buprenorphine initiation strategies
- Explain updated approaches to long-acting injectable buprenorphine initiation
- Identify barriers and facilitators to pharmacist dispensing of buprenorphine and provision of naloxone and syringes
- Describe recent regulatory and policy changes affecting pharmacy-based OUD care.
- Apply evidence-based, non-stigmatizing practices to reduce dispensing delays and improve access to OUD treatment
Course Director:
Susan Skledar, RPh, MPH, FASHP - Director of Experiential Learning, and Professor, University of Pittsburgh School of Pharmacy
Planning Committe:
Amy Seybert, PharmD - Dean, and Professor, University of Pittsburgh School of Pharmacy
Presenter:
Lucas G. Hill, PharmD, FCCP - Associate Professor and Implementation and Research Center for Healthy Communities (IRC) Executive Director, University of Pittsburgh School of Pharmacy
Conflict of Interest Disclosure
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Disclaimer Statement
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (ACPE)
The maximum number of hours awarded for this Continuing Pharmacy Education activity is 2.0 contact hours. JA-
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 2.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 2.00 Attendance
Choose Register/Complete Course to complete the module.
PLEASE NOTE: Your NABP and DOB must be in your profile in order to have credits submitted to the ACPE and pharmacy credits awarded.
First time Users: If you have never completed training on this website, please select register in the upper right hand corner of the webpage.
Returning Users: If you have completed training on this website, please log in in the upper right hand corner of the webpage.